Program as of June 16, 2015 
Thursday, 18 June, 2015
08:00-17:30 Registration
09:00-09:15 Opening Ceremony: Eddy Karnieli, Uzia Galil, Eliezer Shalev, Yehuda Assaraf, Derek Leroith, Hans Haering
09:15-10:00 Plenary Session  I – Chairperson:  Eddy Karnieli
Philippe Froguel, UK –  New Insight into Genetics of Diabetes and Obesity
10:00-10:30 Coffee Break   
10:30-12:30 Oncology A Obesity, Diabetes  A
Chairperson: Yehuda G. Assaraf,  Arie Admon Chairperson: Hans Haering, Benjamin Glaser
Sponsored by Novo Nordisk
10:30-11:00 Avi Schroeder , “Personalized Cancer Nanomedicine” Hans Haring, Germany – Sub-phenotypes of prediabetes:
Is individualized prevention feasible?
11:00-11:30 Ronit Satchi-Fainaro , “Elucidating the Molecular Basis of Tumor Dormancy Using Theranostic Nanomedicines” Benjamin Glaser, Israel -The Pancreatic Islet as a Target for Diabetes Therapy and Toxicity
11:30-12:00 Arie Admon , “The prospect for Personalize Cancer Vaccine Based on Immunopeptidome Analysis” Ofri Mosenzon, Israel  – Role of Clinical Characteristics in Personalizing Diabetes Therapy
12:00-12:30 Yehuda G. Assaraf , “Lysosomal Biogenesis: A Novel Druggable Target for Personalized Cancer Therapeutics” Adriana Fodor, Romania – Potential Venues for Cell Therapy in Diabetes
12:30-13:30 Lunch Break, Poster Session and Exhibition Visit 
13:30-15:30 Oncology B Obesity, Diabetes   B
Chairperson: Gad Rennert, Rudolph Kaaks Chairperson: Francesco Beguinot, Derek Leroith
13:30-14:00 Rudolph Kaaks, Germany -Selecting High-Risk Individuals for Lung Cancer Screening – A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort Francesco Beguinot , Italy  – Epigenetics in Diabetes  –  New Molecular Targets for Life Style Modifications
14:00-14:30 Gad Rennert , Israel- The Promises and Pitfalls of Using Large NGS Panels in Cancer Derek Leroith , Israel & USA – The Role of Hyperlipidemia in Cancer Risk and Mortality
14:30-15:00 Noam Shomron, Israel – DNA and RNA in Precision Medicine  Eddy Karnieli, Israel – Molecular Targets for Obesity Therapy
15:00-15:30 Juliane Stickel , Germany –  A Targeted Approach Toward Peptide-Based Immunotherapy in Oncology  Panel Discussion: Applying molecular knowledge in diabetes/obesity treatment – How close are we?
15:30-15:45 Coffee Break and Exhibition Visit
15:45-17:45 Big Data and Arthritis  Oral Presentations
Chairperson: Amanda Niskar, Yelena Yesha  Chairpersons: Borko Furht, Scott DuVall
15:45-16:15 Amanda Niskar, USA – Strategy for Improving Health Outcomes for People with Arthritis and Related Diseases. 15:45-16:00 Gabi Tarcic, Israel –  Identification of the Functional Significance of Mutations using the Novel Precision Cancer Analysis System
16:15-16:30 Yelena Yesha, USA – Rheumatoid Arthritis Big Data Analytics – Veterans Affairs Informatics and Computing Infrastructure (VINCI). 16:00-16:15 Borko Furht, USA – Developing a Smart Physician/Patient Decision Support Healthcare System
16:30-16:45 Naphtali Rishe, USA – Methods for Moving Towards Pre-Clinical Diagnosis for Rheumatoid Arthritis. 16:15-16:30 Talya Miron-Shatz, Israel – How to Make an Adherence App Appeal to the Elderly: the Case of “Medication Plan”
 16:45-17:45 Panel: U.S. NSF and Israeli Academia&Industry
Panel on Collaboration Opportunities between National Science Foundation Industry/University Cooperative Research Centers and Israeli Academia and Industry


Panel Chairs: Yelena Yesha, Naphtali Rishe, Eddy Karnieli

16:30-16:45 Neta Zach, Israel-  Using the Power of Big Data and Crowdsourcing for Precision Medicine in Amyotrophic Lateral Sclerosis (ALS).
16:45-17:00 Scott DuVall, USA – Mobile GDx – Delivering Genetic and Molecular Diagnositic Test Results
17:00-17:15 Niva Shapira, Israel – Women’s Higher Cancer Risk vs. Men’s Advantage with High n-6 Fatty Acid Intake, Explained by Direct Estrogen-Fatty Acid Effect on DNA Depurination
17:15-17:30 Scott DuVall, USA – Testing for BRCA1/BRCA2 in the Department of Veterans Affairs
17:30-17:45 Scott DuVall, USA – A case study of real–world implementation of IL28B pharmacogenomics testing in the Department of Veterans Affairs
17:45-18:30 Plenary Session  III  – Chairperson: Uzia Galil
17:45-18:30 Tom Ran, Israel –   “Science Fiction – Are We There Yet?”
Friday, 19 June, 2015
08:30-10:00 Plenary Session III – Chairperson: Nachman Ash, Stavit Shalev
08:30-09:00 Eliot Siegel, USA-  Precision Imaging
 09:00-09:30 Alan Shuldiner, USA – Large Scale Human Genetics Applied to Drug Discovery and Development
09:30-10:00 W. Andrew Faucett, USA – Community Engagement and Return-of-Results in DiscovEHR, a Precision Medicine Biobank
10:00-10:30 Coffee Break
10:30-12:00 Implementing of Personalized Medicine at the Point of Care-
Chairpersons: Arnon Afek, Nicky Liberman
10:30-11:00 Varda Shalev, Israel –  Benefits of Big Numbers in the Clinical Settings
11:00-11:30 Lina Basel, Israel –  From Prenatal Genetic Testing to Fetal Personalized Medicine: Current Status and Future Trends
11:30-12:00 Salomon M. Stemmer,  Israel – Translating Translational Medicine into Reality – A Physician’s View
12:00-13:15 Panel Discussion – Moderators: Nicky Liberman, Eddy Karnieli
Discussants: Arnon Afek, Varda Shalev, Alan Shuldiner, Hans Haering, Shlomo Vinkler, Amnon Lahad
13:15-13:30 Concluding Remarks: Uzia Galil, Eddy Karnieli
13:30  Lunch
 13:30  Continued Discussions on Collaboration between National Science Foundation Industry/University Cooperative Research Centers and Israeli Academia and Industry